J. Am. Chem. Soc. 1997, 119, 11331-11332
11331
The successful completion of this synthesis was critically
dependent on three issues: (i) use of acetate protecting groups
for the C(11,13)-diol;11 (ii) use of an allyl ester to protect the
C(10)-carboxyl of 3, thereby facilitating removal of the two
acetates at the end of the synthesis; and (iii) use of acid labile
methoxymethyl (MOM) ethers (see 2) to protect the 1,4-
dihydronaphthoquinone precursors to 1.10 Use of phenolic
MOM ethers was required by our finding that attempted
oxidative demethylation of 4 (and related intermediates) pro-
vided 5 which could not be elaborated to DmD.10 This
necessitated that the 1,4-dihydronaphthoquinone deprotection
and oxidation steps be decoupled.
Total Synthesis of (+)-Damavaricin D
William R. Roush,*,1 D. Scott Coffey, and David J. Madar
Department of Chemistry, Indiana UniVersity
Bloomington, Indiana 47405
ReceiVed June 4, 1997
Damavaricin D (DmD, 1) is both a biosynthetic precursor of
the streptovaricin antibiotic family as well as a degradation
product of streptovaricin D (SvD).2,3 The damavaricins, like
the streptovaricins, are inhibitors of RNA-directed DNA poly-
merase (i.e., reverse transcriptase),4 and certain derivatives have
other interesting biological properties.5 The stereochemistry of
1 has been assigned on the basis of its biosynthetic conversion
into streptovaricin C (SvC),3 the structure and absolute config-
uration of which have been determined by X-ray analysis of a
heavy atom derivative.6 The only stereocenter of DmD/SvD
Acid hydrolysis of 610,12 and reprotection of the phenol as a
tert-butyldiphenylsilyl (TBDPS) ether provided 7 (87% yield)
(Scheme 1). This protecting group switch was required because
bromination of 9 was possible only when the C(19) phenol was
unprotected. Dithionite reduction of 713 followed by in situ
protection of the air-sensitive hydroquinone with MOM-Cl and
50% aqueous NaOH under phase transfer conditions provided
8 in 82% yield. Carboxylation of the aryllithium intermediate
generated from 8 followed by Mitsunobu esterification14 of the
naphthoic acid with â-(trimethylsilyl)ethanol provided 9 in 75%
overall yield. Finally, removal of the TBDPS ether, bromination
of C(18) with N-bromosuccinamide (NBS), and reprotection of
the phenol as a MOM ether provided 2.
Metallation of 2 (1.8 equiv) with n-BuLi (1.5 equiv) in THF
at -100 °C followed by addition of enal 3 (1.0 equiv) provided
a mixture of allylic alcohols (83%) that was oxidized with the
Dess-Martin periodinane to give enone 10 in 94% yield as a
1:1 mixture of atropisomers (Scheme 2).15 After deprotection
of the TBDPS ether (Et3N-HF, CH3CN, 89%),16 the primary
alcohol was oxidized via the Swern protocol17 and the aldehyde
chain extended via Still’s (Z)-selective olefination procedure,18
thereby providing 11 in 72% yield along with 5% of the (E)-
olefin isomer. The carbamate functionality of 12 was then
introduced in 66% yield via a Curtius reaction19 of the carboxylic
acid generated by tetrabutylammonium fluoride mediated depro-
tection of 11.20
Selective reduction of the (Z)-enoate unit of 12 required
careful control of the reaction conditions to prevent competitive
reduction of the C(11) and C(13) acetates. Treatment of 12
with 5 equiv of diisobutylaluminum hydride (DIBAL-H) in THF
at -100 to -78 °C for 1.5 h provided the (Z)-enal 14 (14%),
(Z)-allylic alcohol 13 (33%), and recovered 12 (49%). After
not known with certainty prior to our work is C(14). However,
the stereochemistry proposed for the C(6)-C(14) segment of
DmD/SvD is identical to that found in awamycin.7 We report
herein a total synthesis of damavaricin D, the first synthesis of
any member of this family,8 by a route that utilizes the highly
functionalized bromonaphthalene 2 and the ansa chain aldehyde
39,10 as key intermediates.
(1) Present address: Department of Chemistry, University of Michigan,
Ann Arbor, MI 48109.
(2) Rinehart, K. L.; Shield, L. S. Prog. Chem. Org. Nat. Prod. 1976,
33, 231.
(3) Rinehart, K. L., Jr.; Antosz, F. J.; Deshmukh, P. V.; Kakinuma, K.;
Martin, P. K.; Milavetz, B. I.; Sasaki, K.; Witty, T. R.; Li, L. H.; Ruesser,
F. J. Antibiot. 1976, 29, 201.
(4) Rinehart, K. L.; Clark, T. D.; Moran, D. M.; Gray, L. G.; Cowie, C.
H.; Li, L. H. J. Nat. Cancer Inst. 1977, 58, 239.
(5) n-Pentyldamavaricin Fc (deriving from damavaricin C) is potentially
useful as an antiviral agent and for treatment of adult T-cell leukemia:
Onodera, K.; Ito, S.; Sasaki, K. In Subcellular Biochemistry; Plenum
Press: New York, 1989; Vol. 15, p 69. Ito, S.; Gilljams, G.; Wahern, B.;
Wigzell, H.; Yamamoto, N.; Sasaki, K.; Onodera, K. J. Antibiot. 1990, 43,
1045.
(6) Wang, A. H.-J.; Paul, I. C. J. Am. Chem. Soc. 1976, 98, 4612.
(7) Herlt, A. J.; Rickards, R. W.; Robertson, G. B. Aust. J. Chem. 1992,
45, 309.
(8) For previous synthetic studies on the streptovaricins, see: McCarthy,
P. A. Tetrahedron Lett. 1982, 23, 4199. Trost, B. M.; Pearson, W. H.
Tetrahedron Lett. 1983, 24, 269. Fraser-Reid, B.; Magdzinski, L.; Molino,
B. F.; Mootoo, D. R. J. Org. Chem. 1987, 52, 4495. Fraser-Reid, B.; Molino,
B. F.; Magdzinski, L.; Mootoo, D. R. J. Org. Chem. 1987, 52, 4505. Mootoo,
D. R.; Fraser-Reid, B. J. Org. Chem. 1987, 52, 4511. Schreiber, S. L.; Wang,
Z.; Schulte, G. Tetrahedron Lett. 1988, 29, 4085. Wang, Z.; Schreiber, S.
L. Tetrahedron Lett. 1990, 31, 31. Mottoo, D. R.; Fraser-Reid, B.
Tetrahedron 1990, 46, 185.
(11) The crotylchromium addition used to establish the C(11,12) bond
in our inital approach (ref 9) could not be scaled up. Ultimately, the C(11,-
12) bond was constructed with excellent stereoselectivity via a crotylboration
sequence after first reducing the C(10)-acyl unit to a -CH2OH group.
Subsequent reoxidation of this substituent proceeded with acceptable
efficiency only when C(11)-OH was protected as an acetate (ref 10). Full
details of the synthesis of 3 are provided in the Supporting Information.
(12) Roush, W. R.; Madar, D. J. Tetrahedron Lett. 1993, 34, 1553.
(13) Seitz, U.; Daub, J. Synthesis 1986, 686.
(14) Hughes, D. L. Org. React. 1992, 42, 335.
(15) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
(16) Hunig, S.; Wehner, G. Synthesis 1975, 180.
(17) Tidwell, T. T. Synthesis 1990, 857.
(9) Roush, W. R.; Palkowitz, A. D. J. Org. Chem. 1989, 54, 3009.
(10) Roush, W. R.; Coffey, D. S.; Madar, D. J.; Palkowitz, A. D. J.
Brazil. Chem. Soc. 1996, 7, 327.
(18) Still, W. C.; Gennari, C. Tetrahedron Lett. 1983, 24, 4405.
(19) Ninomiya, K.; Shiori, T.; Yamada, S. Tetrahedron 1974, 30, 2151.
(20) Sieber, P. HelV. Chim. Acta 1977, 60, 2711.
S0002-7863(97)01828-3 CCC: $14.00 © 1997 American Chemical Society